Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Impel NeuroPharma Inc.
DescriptionIntranasal hydromorphone
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat pain in patients who have difficulty tolerating traditional systemically administered opioids
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today